This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity
- Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
- Variation in Positron Emission Tomography Use After Colon Cancer Resection
- Primary Jejunal Adenocarcinoma Incidentally Diagnosed on Positron Emission Tomography/Computed Tomography in a Patient With Metastatic Colorectal Cancer: Suspicion of Lynch Syndrome and Effect on Therapeutic Management
- Prognostic Ability of 18F-FDG PET/CT in the Assessment of Colorectal Liver Metastases
- Doing More Harm than Good? Do Systematic Reviews of PET by Health Technology Assessment Agencies Provide an Appraisal of the Evidence That Is Closer to the Truth than the Primary Data Supporting Its Use?
- Are Health Economics Making Us Sick?
- NCCN Task Force: Clinical Utility of PET in a Variety of Tumor Types